Acadia Healthcare Company Inc. Common Stock (ACHC)
Stock · NASDAQ · Health Care
$29.98as of 10/16/2026
Price chart
Active signals
ACHC Signal Track Record
How signals performed across all stocks →What ACHC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 37 | -1.4% | 46% | September 18, 2026 |
| Bollinger Band Breakdown | 25 | -0.4% | 48% | October 1, 2026 |
| Bollinger Band Breakout | 21 | -3.7% | 38% | June 26, 2026 |
| 200-Day Moving Average TouchActive now | 11 | +0.9% | 55% | August 15, 2024 |
| Any 20-session window (baseline) | -1.2% | 45% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ACHC
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare s…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 25,000
- Website
- www.acadiahealthcare.com/
Fundamentals
- 1-day range
- $29.84$31.89
- Market cap
- $2.86B
- P/E (trailing)
- —
- P/E (forward)
- 17.15
- EPS (trailing)
- $-12.46
- Dividend yield
- —
- Beta
- 0.64
- Avg. volume
- 1.93M
How Acadia Healthcare Company Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 27, 2026 · via SEC EDGAR / Finnhub
Forecasts
14 analyst ratings
Acadia Healthcare Company Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ACHCAcadia Healthcare Company Inc. Common Stock$29.98▼ 3.41%Market cap $2.86BP/E —$11.43$35.83
- ALHCAlignment Healthcare Inc. Common Stock$8.28▲ 1.60%Market cap $2.78BP/E 41.54$6.01$25.12
- GRALGRAIL Inc. Common Stock$117.81▼ 13.03%Market cap $2.72BP/E —$41.5$166.48
- CLOVClover Health Investments Corp. Class A Common Stock$4.48▼ 4.27%Market cap $2.45BP/E —$1.58$5.59
- CDNACareDx Inc. Common Stock$64▼ 4.01%Market cap $2.32BP/E 30.15$14.03$72.51
- VCYTVeracyte Inc. Common Stock$43.12▼ 2.86%Market cap $3.71BP/E 31.17$29.46$60.91
- CONConcentra Group Holdings Parent Inc. Common Stock$38.54▼ 1.56%Market cap $3.91BP/E 24.09$18.55$38.07
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company Inc. Common Stock | $2.86B | — | $29.98 | ▼ 3.41% | $11.43$35.83 |
| ALHC Alignment Healthcare Inc. Common Stock | $2.78B | 41.54 | $8.28 | ▲ 1.60% | $6.01$25.12 |
| GRAL GRAIL Inc. Common Stock | $2.72B | — | $117.81 | ▼ 13.03% | $41.5$166.48 |
| CLOV Clover Health Investments Corp. Class A Common Stock | $2.45B | — | $4.48 | ▼ 4.27% | $1.58$5.59 |
| CDNA CareDx Inc. Common Stock | $2.32B | 30.15 | $64 | ▼ 4.01% | $14.03$72.51 |
| VCYT Veracyte Inc. Common Stock | $3.71B | 31.17 | $43.12 | ▼ 2.86% | $29.46$60.91 |
| CON Concentra Group Holdings Parent Inc. Common Stock | $3.91B | 24.09 | $38.54 | ▼ 1.56% | $18.55$38.07 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Acadia Healthcare Provides Notice of Proposed Derivative Action SettlementYahoo · 9/25/2026
- Acadia Healthcare Announces Proposed Settlement Of Shareholder Derivative LawsuitsBenzinga · 9/25/2026
- Squeeze Watch: 10 Stocks With Over 33% Short InterestBenzinga · 9/25/2026
- Hospital Chains Stocks Q2 Results: Benchmarking Acadia Healthcare (NASDAQ:ACHC)Yahoo · 9/24/2026
- Leerink Partners Maintains Market Perform on Acadia Healthcare Co, Raises Price Target to $33Benzinga · 9/23/2026
- Acadia Healthcare Jumps 100% YTD on Improving Outlook and ExpansionYahoo · 9/22/2026
- How Acadia Healthcare Is Turning Capacity Growth Into Cash FlowYahoo · 9/22/2026
- Acadia Healthcare Company (ACHC) Heads To Jefferies Conference, Is It Still A Bargain?Yahoo · 9/18/2026
Insider Activity
Insider Actions →- Farley Brian · July 26, 2026 · Tax Withholding1.8K @ $34.51
- Farley Brian · June 26, 2026 · Tax Withholding1.4K @ $26.24
- Bissell E. Perot · May 6, 2026 · Grant6.3K
- Cancelmi Daniel J · May 6, 2026 · Grant6.3K
- GRIECO WILLIAM · May 6, 2026 · Grant6.3K
- Fucci Michael · May 6, 2026 · Grant6.3K
- KELLY RALPH DAVID · May 6, 2026 · Grant6.3K
- Bernhard Jason · May 6, 2026 · Grant5.1K
- Bernhard Jason · May 6, 2026 · Grant6.3K
- Harris Patrice A · May 6, 2026 · Grant6.3K
- Vicky B. Gregg · May 6, 2026 · Grant6.3K
- WAUD REEVE B · May 6, 2026 · Grant9.6K
- WAUD REEVE B · May 6, 2026 · Grant6.3K
- Bissell E. Perot · May 6, 2026 · Grant5.5K
- Farley Brian · May 5, 2026 · Tax Withholding5.1K @ $27.69
Institutional Ownership
March 31, 2026
- Total shares held
- 130.27M
- Total value held
- $3.01B
- Institutional holders
- 290
- Unknown11.69M
- Unknown9.07M
- Unknown6.87M
- Unknown5.19M
- Unknown4.52M
- Unknown4.52M
- Unknown4.49M
- Unknown4.38M
- Unknown4.15M
- Unknown3.84M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Acadia Healthcare Sets Q3 2026 Earnings Date
Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.
Acadia Healthcare Sets Q3 2026 Earnings Date. Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.